This excerpt taken from the SNY 6-K filed Mar 26, 2007.
(insulin glulisine [rDNA origin])
APIDRA® is a new, rapid-acting insulin analog for adult patients with type 1 and type 2 diabetes for the control of hyperglycaemia. APIDRA® offers patients mealtime dosing flexibility—it can be taken within 15 minutes before or after starting a meal. APIDRA® is also flexible for use in patients with a variety of body types, from lean to obese.